Metagenomic Analysis of the Oral Microbiome in Patients With Oral Lichen Planus: A Pilot Study in the Turkish Population
NCT ID: NCT07137156
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2023-12-15
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Lichen Planus and Systemical Oncological Comorbidities
NCT06449248
Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus
NCT02443311
Chamaemelum Nobile 2% Versus Placebo Topic Gel to Treat Oral Lichen Planus
NCT02421770
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
NCT05973097
Effect of Bifidobacterium Animalis Subsp. Lactis HN019 on Oral Lichen Planus
NCT03386643
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Andreassen (21) classified the clinical types of OLP as follows:
1. Reticular: Characterized by small gray-white papules that do not separate from the mucosa when wiped. They are typically located on the cheek mucosa and are symmetrical. These papules may have a thin erythematous border, and these formations often resemble a net or leaf veins (Wickham's lines).
2. Papular: Fine, linear extensions are seen around white hyperkeratotic formations that are 0.5-1 mm in diameter and raised above the surface.
3. Hypertrophic: These are dense white formations that are raised above the surface, particularly seen in smokers. Clinically, this type of OLP is difficult to distinguish from leukoplakia. Wickham's lines around the lesion may aid in establishing a preliminary diagnosis of lichen planus.
4. Atrophic: In this type, erythema is prominent and there is thinning of the epithelium. Those localized in the gingiva may transform into pemphigoid gingivitis. It may occur in conjunction with erosive and bullous OLP. This type may show a possibility of malignant formation. e. Erosive: This is the most common clinical type of OLP, characterized by erosions covered with dense fibrin and shallow ulcers. Erosions cause a burning sensation in OLP patients. This complaint may increase with mechanical, chemical, and thermal irritation associated with food intake.
Despite significant efforts over the past two decades to determine the etiology of OLP, the exact mechanism remains unclear. Previous studies have shown that T cells are involved in the pathogenesis of the disease, but their specific roles in this process remain unclear. Generally, an exogenous antigen, autoantigen, or superantigen triggers an inflammatory response leading to apoptosis of basal epithelial keratinocytes in the oral epithelium, resulting in chronic inflammation. A more plausible theory suggests that multiple antigens, combined with various environmental factors, trigger an inflammatory process. Therefore, the etiology is expected to be multifactorial, as in many other diseases, rather than a single causal factor, which is the approach most researchers use to study OLP.
Studies specific to OLP have shown that rigorous oral hygiene and plaque control can improve gingival lichen planus lesions, suggesting that the oral microbiome may play a role in the onset or exacerbation of OLP. The role of the oral microbiome has also been examined in other inflammatory oral mucosal disorders, such as recurrent aphthous stomatitis and geographic tongue, as well as in other autoimmune diseases, including Sjögren's syndrome, rheumatoid arthritis, and systemic lupus erythematosus. Additionally, recent studies on burning mouth syndrome have also shown that the oral microbiome is effective. Although the exact role of the oral microbiome in the pathogenesis of these conditions remains unclear, it can be suggested that it may also play a role in OLP.
Studies on the relationship between oral bacteria and OLP are available. He et al., in their study evaluating the bacterial composition of the buccal mucosa in patients with oral lichen planus, collected buccal swab samples from 43 patients with oral lichen planus (21 erosive and 22 non-erosive) and 21 healthy mucosal volunteers, and found that 94.26% of the total bacteria were classified into 15 genera present in large quantities. In all cases, Streptococcus, Prevotella, Haemophilus, Neisseria, Fusobacterium, Leptotrichia, Veillonella, and Actinomyces species were detected. In the study, Streptococcus was more prevalent in the healthy control group (p \<0.01), while Fusobacterium (p \< 0.01), Leptotrichia (P \< 0.001), and Lautropia (P \< 0.001) were more prevalent in the OLP group.
Compared to healthy control subjects, studies have shown that there is dysbiosis in the mucosal bacterial composition and salivary microbiota in OLP patients, and that there is a difference between affected and unaffected areas in the same patient. The literature also reports that certain species damage the epithelial barrier, invade the lamina propria, and internalize epithelial cells or T cells, leading to the production of specific T-cell chemokines.
The aim of this study was to determine the metagenomic profile analysis of relevant oral pathogens in patients with oral lichen planus.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral lichen planus
buccal smear
cytobrush
buccal smear
next-generation sequencing
next-generation sequencing
oral lichen planus healty
buccal smear
next-generation sequencing
next-generation sequencing
control
buccal smear
next-generation sequencing
next-generation sequencing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cytobrush
buccal smear
next-generation sequencing
next-generation sequencing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 18 and 75,
* Individuals with OLP that has clinical and histopathological characteristics according to the World Health Organization FOR HEALTHY INDIVIDUALS; CRITERIA FOR PARTICIPATION IN THE STUDY
* Individuals who agree to participate in the study,
* Aged between 18 and 75,
* Healthy individuals with no systemic disorders
Exclusion Criteria
* Individuals with systemic disorders (autoimmune diseases, hematological diseases, diabetes mellitus, hypertension, infectious diseases, allergic conditions),
* Use of systemic or topical medication for OLP within the last six months, FOR HEALTHY INDIVIDUALS;
CRITERIA FOR EXCLUSION FROM THE STUDY
• Individuals with OLP and other autoimmune-related oral mucosal diseases,
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AYŞE GÜL ÖNER TALMAÇ
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ayşe Gül Öner Talmaç
Kahramanmaraş, Kahramanmaraş, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AysegulOralLichen
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.